Description
| Product Name | CAT.No | Size |
| Plasma Calibrator | COAG125A | 1 x 1ml |
| Plasma Control Level 1 | COAG108A | 1 x 1ml |
| Plasma Control Level 1 | COAG108B | 5 x 1ml |
| Plasma Control Set Level 1 & 2 | COAG112A | 2 x 5 x 1ml |
| Plasma Control Level 2 | COAG109A | 1 x 1ml |
| Plasma Control Level 2 | COAG109B | 5 x 1ml |
Product Description
The Biorex Diagnostics Plasma Controls are human plasma–based, ready-to-use materials designed to provide accurate, precise, and reproducible quality control for coagulation assays. These controls are essential for evaluating the performance of Prothrombin Time (PT), Activated Partial Thromboplastin Time (APTT), and Fibrinogen tests, ensuring reliable results that guide the diagnosis and management of bleeding disorders, clotting abnormalities, and anticoagulant therapy.
Prepared using human plasma, these controls closely mimic patient samples, providing clinically relevant conditions for laboratory testing. Multiple levels are supplied to cover low, normal, and high ranges, supporting comprehensive performance assessment across the entire analytical spectrum. The ready-to-use format reduces preparation errors, streamlines workflow, and maintains consistent results, helping laboratories meet international quality standards.
Key Features
- Human plasma-based – replicates patient samples for clinically meaningful QC.
- Multi-level controls – available in low, normal, and high levels for complete assay verification.
- Ready-to-use formulation – simplifies handling and ensures reproducible results.
- Supports coagulation assays – validated for PT, APTT, and Fibrinogen testing.
- Stable and reliable – maintains performance over time for long-term laboratory use.
- Wide analyser compatibility – suitable for automated and semi-automated coagulation platforms.
Benefits
Routine use of Biorex Controls enables laboratories to maintain high standards in coagulation testing. By providing reliable QC, laboratories can monitor assay precision, detect deviations early, and verify instrument accuracy, supporting dependable clinical results. Accurate PT and APTT measurements aid in the assessment of haemophilia, thrombophilia, liver disease, and disseminated intravascular coagulation (DIC), while Fibrinogen testing evaluates clotting efficiency and haemostatic function. Incorporating these controls strengthens quality assurance, ensures compliance with ISO 15189, CAP, and CLIA standards, and enhances confidence in diagnostic decision-making. Suitable for both clinical and research applications, the Biorex Diagnostics Plasma Controls provide consistent, reliable performance for comprehensive coagulation monitoring, ultimately supporting improved patient care and laboratory reliability.
Contact Us for more information.